HDFC Life is scheduled to hold a Committee meeting on December 8, 2025, to approve the commercial terms for the proposed issuance of subordinated debt instruments. The issuance, in the form of Non-convertible Debentures (NCDs), will be up to ₹750 crore on a private placement basis. The company had already received in-principle approval from its Board for raising funds through this instrument.
Subordinated Debt Issuance Approval
HDFC Life is moving forward with its plan to issue subordinated debt instruments to raise funds. The company announced that a meeting of the Capital Raising Committee (CRC) is scheduled for December 8, 2025, to approve the commercial terms of this issuance.
Details of the Proposed Issuance
The proposed issuance will be in the form of Non-convertible Debentures (“NCDs”) up to ₹750 crore (Indian Rupees seven hundred fifty crore). These NCDs will be issued in one or more tranches on a private placement basis, subject to the terms and conditions finalized by the Capital Raising Committee of the Board (“CRC”). The initial in-principle approval for this fundraising was granted by the Board on October 15, 2025.
Nature of the Instrument
The NCDs will be unsecured, rated, listed, redeemable, fully paid-up, non-cumulative, and subordinated, adhering to a private placement basis. The funds raised will be utilized to support the company’s growth and expansion plans.
Source: BSE
